相关实验视频
Updated: Jun 26, 2025

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.3K
TFCP2L1,一个潜在的分化调节器,预测有利的预后,减缓甲状腺癌的进展
1Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510000, China.
Journal of endocrinological investigation
|May 16, 2024
概括
转录因子CP2-like 1 (TFCP2L1) 在甲状腺癌中被下调,作为瘤抑制剂. 它的减少表达与预后不佳相关,并抑制分化,表明TFCP2L1是潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 甲状腺癌的发病率很高,需要对其机制进行研究,以获得新的治疗策略.
- 转录因子CP2-like 1 (TFCP2L1) 在甲状腺癌进展中的特定作用目前尚不清楚.
研究的目的:
- 研究甲状腺癌中TFCP2L1的表达,功能和机制.
- 为了确定TFCP2L1是否可以作为预后标记或治疗点.
主要方法:
- 在公共数据库和临床甲状腺癌样本中分析TFCP2L1表达.
- 生存分析 (卡普兰-梅尔,考克斯回归) 与TFCP2L1水平与患者结局相关.
- 在体外和体外功能测试以评估TFCP2L1对癌细胞行为的影响.
- RNA测序以识别TFCP2L1-调节的信号通路,包括NF-κB.
主要成果:
- 与正常组织相比,甲状腺瘤中的TFCP2L1表达显著下调.
- 较低的TFCP2L1水平与不良的临床病理特征和较短的无疾病/无进展间隔有关.
- 过度表达TFCP2L1抑制了甲状腺癌细胞的生长,运动性,瘤性和转移,并禁用了NF-κB通路.
结论:
- 在甲状腺癌中,TFCP2L1作为瘤抑制剂和分化调节剂起作用.
- TFCP2L1代表了甲状腺癌治疗的有前途的治疗标.
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Synthesis and Regulation of Thyroid Hormones
4.6K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

